CVRX Company Profile and Key Details

CVRX has shown weak momentum, losing -23.53% over the past week and -43.82% over the past quarter, though year-to-date performance is down -21.27%. Short-term trend indicators are bullishly aligned (SMA20 25.42%, SMA50 16.43%, SMA200 5.35%). The stock’s 14-day RSI is 64.66 (firm momentum), while the ATR of 0.7 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -42.51% below its high and over 87.47% above its low. Average 10-day trading volume of 186.85 thousand shares is below the 3-month average of 358.11 thousand, indicating normal recent market interest.

CVRx, Inc. generated EPS of -$2.04 over the past year. Five-year average earnings growth is -22.44%. Wall Street analysts project EPS growth of 6.41% annually over the next five years. The latest quarter delivered EPS of -$0.49. The next quarter is forecast at -$0.52. Next year's EPS is expected at $4.05. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $18.00 to $11.00. The high target offers 128.72% upside. The low target suggests 39.77% downside. The mean target is $13.00. This offers 65.18% upside. CVRx, Inc. earnings surprise history is a mixed track record. The quarter that ended November 05, 2025, missed forecasts by -2.0%. The prior quarter beat by 9.62%. Over the last six quarters, Apple has recorded several small beats. These include 27.45% in July 29, 2024.

CVRx, Inc. has 26.07 million shares outstanding. The public float is 17.96 million shares, elevated short interest at 9.91% of float. This equals 1.91 million shares. The short ratio is 6.94 days. Institutional investors hold 70.92% of the float. Insiders own 4.31%. JOHNSON & JOHNSON holds 4.02 million shares, NEW ENTERPRISE ASSOCIATES 10 L P has 2.03 million shares and Nielsen Kirk G. has 1.91 million shares. Over the past six months, insider transactions show net selling. They sold 94.59 thousand shares across 12 transactions.

CVRx, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.18. This means the shares are trading below this model’s fair value.

CVRx, Inc. (NASDAQ:CVRX) closed at $8.07 USD, gaining $0.20 (2.60%) from the previous close of $7.87. The stock is currently mid-range between its 52-week high and low $4.30 and $13.34. With a market capitalization of about $212.47 million, CVRx, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.24). Key stats such as the average daily volume over the past year has been around 359.67 thousand shares, volume is running light vs its 52-week average. Headquartered in Minneapolis, MN, CVRx, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Kevin Hykes, the company employs approximately 206 people and listed since June 30, 2021. CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.

Our AI price prediction model suggests that CVRx, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.07%, with price expected at $8.19 by March 30, 2026, within a range of $7.06 to $9.23 3-Month Outlook: Projected rise of 2.29%, reaching $8.05 by June 12, 2026, with a range of $7.23 to $8.77. 1-Year Outlook: Projected loss of -9.53%, with price at $7.12 by March 16, 2027, within a range of $0.00 to $5.29.

CVRx, Inc. (NASDAQ:CVRX) shares are down -21.27% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVRx, Inc. trading at a premium to the broader market with a P/E of -3.87. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $16.44, suggesting 108.89% upside. Our AI forecast model points to short-term strength (4.07% over two weeks), a medium-term rise (2.29% over three months), and a longer-term loss (-9.53% over one year), with expected trading ranges indicating moderate volatility.

CVRx, Inc. trades at a P/E ratio of -3.87, slightly below the S&P 500 average, with a price-to-sales ratio of 3.66 and a price-to-book ratio of 5.25 trading at moderately above to book value. The P/FCF stands at -5.08, also below market averages.